STAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and more

17 pharmaceutical companies spent over $130 million on federal lobbying in 2025, a 23% surge, as the TrumpRx prescription drug-pricing program was being shaped. Eli Lilly paused its obesity awareness campaign in India after the nation's drugs regulator warned of potential rule violations. The campaign aimed to reframe obesity as a chronic disease.